Cart
sales@molnova.com
Incyclinide
CAS No. 15866-90-7
Incyclinide( CMT-3 | COL-3 )
Catalog No. M23692 CAS No. 15866-90-7
Incyclinide is a matrix metalloproteinase (MMP) inhibitor. Thereby causing extracellular matrix degradation, tumor growth and invasion, and inhibiting angiogenesis, and metastasis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 110 | In Stock |
|
| 10MG | 178 | In Stock |
|
| 25MG | 384 | In Stock |
|
| 50MG | 583 | In Stock |
|
| 100MG | 831 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIncyclinide
-
NoteResearch use only, not for human use.
-
Brief DescriptionIncyclinide is a matrix metalloproteinase (MMP) inhibitor. Thereby causing extracellular matrix degradation, tumor growth and invasion, and inhibiting angiogenesis, and metastasis.
-
DescriptionIncyclinide is a matrix metalloproteinase (MMP) inhibitor. Thereby causing extracellular matrix degradation, tumor growth and invasion, and inhibiting angiogenesis, and metastasis.
-
In Vitro——
-
In Vivo——
-
SynonymsCMT-3 | COL-3
-
PathwayMetabolic Enzyme/Protease
-
TargetMMP
-
RecptorMT1-MMP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number15866-90-7
-
Formula Weight371.34
-
Molecular FormulaC19H17NO7
-
Purity>98% (HPLC)
-
SolubilityDMSO:95 mg/mL (255.83 mM)
-
SMILESNC(C(C(C[C@H](C[C@H](Cc1cccc(O)c11)C(C2=O)=C1O)[C@]21O)=O)=C1O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lee HM, et al. CMT-3, a non-antimicrobial tetracycline (TC), inhibits MT1-MMPactivity: relevance to cancer. Curr Med Chem. 2001 Feb;8(3):257-60.
molnova catalog
related products
-
IK-862
IK-862 is a selective inhibitor of TACE (ADAM17).
-
CTTHWGFTLC, CYCLIC
This cyclic CTT Gelatinase Inhibitor peptide is an inhibitor for matrix metalloproteinases (MMP)-2 and MMP-9. It is also called type IV collagenase or gelatinase. Gelatinases are potential targets of therapeutic intervention in cancer, and inhibitors of these enzymes can prevent tumor progression.
-
KP-457
KP-457 is a specific inhibitor of a disintegrin-metalloproteinase 17 (ADAM17) and a TNFα converting enzyme TACE inhibitor that blocks the production of soluble TNF (sTNF).
